These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of Chen Q; Lin G; Huang J; Chen L; Liu Y; Huang J; Zhang S; Lin Q Aging (Albany NY); 2020 Jan; 12(2):1899-1909. PubMed ID: 32003752 [TBL] [Abstract][Full Text] [Related]
3. MALAT1 affects hypoxia-induced vascular endothelial cell injury and autophagy by regulating miR-19b-3p/HIF-1α axis. Liu H; Shi C; Deng Y Mol Cell Biochem; 2020 Mar; 466(1-2):25-34. PubMed ID: 31933110 [TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes Hypertension by Modulating the Hsa-miR-124-3p/Nuclear Receptor Subfamily 3, Group C, Member 2 (NR3C2) and Hsa-miR-135a-5p/NR3C2 Axis. Luo L; Wang Y; Hu P; Wu J Med Sci Monit; 2020 Mar; 26():e920478. PubMed ID: 32222724 [TBL] [Abstract][Full Text] [Related]
5. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p. Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809 [TBL] [Abstract][Full Text] [Related]
6. LncRNA MALAT1 inhibits hypoxia/reoxygenation-induced human umbilical vein endothelial cell injury via targeting the microRNA-320a/RAC1 axis. Zhu R; Hu X; Xu W; Wu Z; Zhu Y; Ren Y; Cheng L Biol Chem; 2020 Feb; 401(3):349-360. PubMed ID: 31408432 [TBL] [Abstract][Full Text] [Related]
7. The lncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis. Zhao C; Zong Z; Zhu Q; Wang Y; Li X; Zhang C; Ma C; Xue Y Vascul Pharmacol; 2021 Jun; 138():106841. PubMed ID: 33545365 [TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1 aggravates human microvascular endothelial cell injury by inhibiting the Apelin/Nrf2/HO-1 signalling pathway in type 2 diabetes mellitus with obstructive sleep apnoea. Chen K; Ou B; Huang Q; Deng D; Xiang Y; Hu F Epigenetics; 2024 Dec; 19(1):2293409. PubMed ID: 38232183 [TBL] [Abstract][Full Text] [Related]
9. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs. Guo X; Liu Y; Zheng X; Han Y; Cheng J Life Sci; 2020 May; 248():117445. PubMed ID: 32081664 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1/miR-370-3p/HMGB1 axis. Xu L; Hu G; Xing P; Zhou M; Wang D Life Sci; 2020 Dec; 262():118505. PubMed ID: 32998017 [TBL] [Abstract][Full Text] [Related]
11. Ox-LDL-induced lncRNA MALAT1 promotes autophagy in human umbilical vein endothelial cells by sponging miR-216a-5p and regulating Beclin-1 expression. Wang K; Yang C; Shi J; Gao T Eur J Pharmacol; 2019 Sep; 858():172338. PubMed ID: 31029709 [TBL] [Abstract][Full Text] [Related]
12. The knockdown of MALAT1 inhibits the proliferation, invasion and migration of hemangioma endothelial cells by regulating MiR-206 / VEGFA axis. Wang S; Ren L; Shen G; Liu M; Luo J Mol Cell Probes; 2020 Jun; 51():101540. PubMed ID: 32084582 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding TUG1 promotes angiogenesis of HUVECs in PE via regulating the miR-29a-3p/VEGFA and Ang2/Tie2 pathways. Liu Z; Guo N; Zhang XJ Microvasc Res; 2022 Jan; 139():104231. PubMed ID: 34352236 [TBL] [Abstract][Full Text] [Related]
14. LncRNA TTTY15 regulates hypoxia-induced vascular endothelial cell injury via targeting miR-186-5p in cardiovascular disease. Zheng J; Zhuo YY; Zhang C; Tang GY; Gu XY; Wang F Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3293-3301. PubMed ID: 32271447 [TBL] [Abstract][Full Text] [Related]
15. MiR-141-3p downregulation promotes tube formation, migration, invasion and inhibits apoptosis in hypoxia-induced human umbilical vein endothelial cells by targeting Notch2. Ling Z; Chen M; Li T; Qian Y; Li C Reprod Biol; 2021 Jun; 21(2):100483. PubMed ID: 33631423 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MALAT1 modulates myocardial ischemia-reperfusion injury through the PI3K/Akt/eNOS pathway by sponging miRNA-133a-3p to target IGF1R expression. Liu XM; Zhang Z; Zhong J; Li N; Wang T; Wang L; Zhang Q Eur J Pharmacol; 2022 Feb; 916():174719. PubMed ID: 34968461 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FKSG29 regulates oxidative stress and endothelial dysfunction in obstructive sleep apnea. Chen YC; Hsu PY; Su MC; Chen YL; Chang YT; Chin CH; Lin IC; Chen YM; Wang TY; Lin YY; Lee CP; Lin MC; Hsiao CC Mol Cell Biochem; 2024 Oct; 479(10):2723-2740. PubMed ID: 37914826 [TBL] [Abstract][Full Text] [Related]
18. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway. Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Sun R; Zhang L Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417 [TBL] [Abstract][Full Text] [Related]
20. Significant role of long non-coding RNA MALAT1 in deep vein thrombosis via the regulation of vascular endothelial cell physiology through the microRNA-383-5p/BCL2L11 axis. Wang H; Lin S; Yang Y; Zhao M; Li X; Zhang L Bioengineered; 2022 May; 13(5):13728-13738. PubMed ID: 35706417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]